This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
infected cells | 549 |
type i | 404 |
viral rna | 394 |
virus infection | 375 |
gene expression | 349 |
virus replication | 348 |
influenza virus | 335 |
viral replication | 307 |
previously described | 270 |
wild type | 263 |
rna synthesis | 250 |
rna viruses | 244 |
respiratory syndrome | 240 |
rna replication | 211 |
innate immune | 210 |
immune response | 210 |
i ifn | 207 |
acute respiratory | 202 |
amino acid | 200 |
cell lines | 194 |
host cell | 190 |
virus particles | 180 |
severe acute | 176 |
infected mice | 173 |
protein vi | 170 |
mg ml | 160 |
hela cells | 159 |
western blot | 159 |
wt mice | 151 |
viral infection | 148 |
cell surface | 146 |
immune responses | 145 |
rna polymerase | 145 |
influenza viruses | 145 |
described previously | 143 |
time points | 143 |
vesicular stomatitis | 140 |
room temperature | 139 |
syndrome coronavirus | 138 |
sialic acid | 138 |
ebov gp | 138 |
performed using | 137 |
ebola virus | 136 |
viral proteins | 135 |
receptor binding | 135 |
cell culture | 134 |
independent experiments | 133 |
west nile | 133 |
viral load | 133 |
stomatitis virus | 132 |
plos pathog | 129 |
doc id | 129 |
cord uid | 129 |
pathog doi | 129 |
post infection | 127 |
plasma membrane | 125 |
nile virus | 123 |
determine whether | 123 |
flow cytometry | 121 |
viral genome | 118 |
prp sc | 117 |
strand rna | 116 |
capsid protein | 116 |
dengue virus | 115 |
genomic rna | 115 |
sindbis virus | 114 |
total rna | 114 |
rna virus | 113 |
virus type | 113 |
hepatitis virus | 112 |
well plates | 112 |
membrane fusion | 112 |
protein kinase | 110 |
alb ts | 109 |
plaque assay | 109 |
binding site | 108 |
respiratory syncytial | 108 |
virus rna | 107 |
syncytial virus | 107 |
wnv infection | 106 |
host factors | 106 |
amino acids | 103 |
cell death | 103 |
crystal structure | 103 |
viral dna | 102 |
cells infected | 101 |
fusion protein | 100 |
rlr signaling | 100 |
cells expressing | 100 |
mm tris | 99 |
cell entry | 99 |
endoplasmic reticulum | 99 |
mm nacl | 98 |
cell lysates | 97 |
treated cells | 97 |
vaccinia virus | 96 |
i interferon | 96 |
deficient mice | 95 |
cell types | 94 |
dendritic cells | 94 |
epithelial cells | 94 |
mouse hepatitis | 94 |
infectious virus | 94 |
mice infected | 91 |
blot analysis | 90 |
transfected cells | 90 |
cell line | 90 |
viral particles | 89 |
chikungunya virus | 89 |
pi ka | 87 |
previous studies | 87 |
days post | 87 |
viral entry | 86 |
data suggest | 86 |
virus titers | 86 |
hours post | 85 |
infectious diseases | 85 |
virus entry | 85 |
viral protein | 85 |
human cells | 84 |
immunodeficiency virus | 84 |
protein synthesis | 83 |
control cells | 83 |
expression levels | 83 |
time point | 83 |
fiber head | 82 |
core protein | 80 |
spike protein | 80 |
may also | 80 |
dependent rna | 80 |
deficient cells | 79 |
stranded rna | 79 |
monoclonal antibody | 78 |
viral titers | 78 |
human cytomegalovirus | 77 |
herpes simplex | 77 |
also observed | 77 |
taken together | 77 |
life cycle | 77 |
simplex virus | 76 |
positive cells | 76 |
luciferase activity | 76 |
sars coronavirus | 76 |
neutralizing antibodies | 75 |
fatty acid | 75 |
rna helicases | 74 |
terminal domain | 74 |
three independent | 74 |
closely related | 74 |
virus production | 74 |
strand synthesis | 73 |
protein expression | 73 |
nonstructural protein | 73 |
mdck cells | 73 |
respiratory tract | 72 |
class i | 71 |
mh mn | 70 |
host proteins | 70 |
dependent manner | 70 |
rna helicase | 69 |
three times | 69 |
recombination events | 68 |
host cells | 68 |
hcv infection | 68 |
high levels | 68 |
standard deviation | 68 |
tissue culture | 68 |
previously reported | 67 |
na activity | 67 |
innate immunity | 67 |
results indicate | 67 |
nipah virus | 67 |
cleavage site | 66 |
human immunodeficiency | 66 |
secondary antibodies | 66 |
target cells | 66 |
mrna levels | 66 |
vero cells | 66 |
viral gene | 65 |
ifit mice | 65 |
per well | 64 |
mammalian cells | 64 |
coiled coil | 64 |
ns protein | 64 |
tombusvirus replicase | 63 |
species transmission | 63 |
vvdedk rhtrs | 63 |
cut sites | 63 |
rabbit anti | 63 |
ppxy motif | 63 |
kindly provided | 63 |
signaling pathway | 63 |
secretory pathway | 63 |
western blotting | 62 |
cell fusion | 62 |
ts mutants | 62 |
di particles | 61 |
weight loss | 61 |
middle east | 61 |
cell responses | 61 |
signaling proteins | 61 |
viral genomes | 61 |
coding region | 60 |
structural protein | 60 |
open reading | 60 |
new world | 60 |
reverse transcription | 60 |
mutant virus | 60 |
ma virus | 60 |
encephalitis virus | 59 |
dna replication | 59 |
type mice | 59 |
coronavirus spike | 59 |
thermo fisher | 58 |
negative control | 58 |
nervous system | 58 |
bovine serum | 58 |
viral mrna | 58 |
mhv spike | 58 |
post transfection | 58 |
crystal structures | 58 |
cell response | 57 |
final concentration | 57 |
east respiratory | 57 |
dub activity | 57 |
important role | 57 |
sendai virus | 57 |
electron microscopy | 57 |
tbsv replication | 57 |
structural proteins | 57 |
interaction sites | 57 |
binding domain | 57 |
mm edta | 57 |
antiviral activity | 57 |
rl mice | 57 |
listeria monocytogenes | 57 |
determined using | 56 |
host species | 56 |
highly conserved | 56 |
antiviral response | 56 |
acid binding | 56 |
medium containing | 56 |
lysis buffer | 55 |
intercellular movement | 55 |
cov infection | 55 |
mouse model | 55 |
life technologies | 55 |
washed twice | 55 |
immune system | 54 |
goat anti | 54 |
reovirus infection | 54 |
confocal microscopy | 54 |
human tfr | 54 |
ng ml | 54 |
rsv infection | 54 |
cell type | 54 |
matrix protein | 54 |
hemorrhagic fever | 53 |
adaptive immune | 53 |
hsp isoforms | 53 |
reassortant viruses | 53 |
enveloped viruses | 53 |
mapk erk | 53 |
binding protein | 52 |
central nervous | 52 |
significantly reduced | 52 |
public health | 52 |
genome replication | 52 |
critical role | 51 |
mm hepes | 51 |
fusion proteins | 51 |
coronavirus infection | 51 |
mutant viruses | 51 |
virus infections | 51 |
human metapneumovirus | 51 |
nucleic acid | 51 |
united states | 50 |
error bars | 50 |
translation initiation | 50 |
analyzed using | 50 |
two independent | 50 |
results suggest | 50 |
data indicate | 50 |
avian influenza | 50 |
significantly higher | 49 |
sud core | 49 |
cellular proteins | 49 |
protein levels | 49 |
ge healthcare | 49 |
like receptor | 49 |
body weight | 49 |
host range | 49 |
cellular mrnas | 48 |
host mrna | 48 |
day post | 48 |
low ph | 48 |
pcr products | 48 |
genetic diversity | 47 |
viral infections | 47 |
interaction site | 47 |
low levels | 47 |
transcription factor | 47 |
ifn production | 47 |
two different | 47 |
expressing cells | 47 |
rna binding | 47 |
stat phosphorylation | 47 |
bd biosciences | 47 |
iav entry | 47 |
statistical significance | 47 |
sev cantell | 47 |
cells treated | 46 |
significant differences | 46 |
defective interfering | 46 |
trex bcbl | 46 |
vsv infection | 46 |
rvfv infection | 46 |
like protease | 46 |
essential role | 46 |
murine coronavirus | 46 |
conformational changes | 45 |
secondary antibody | 45 |
er stress | 45 |
activated protein | 45 |
rd cells | 45 |
cellular rna | 45 |
cells using | 45 |
spinal cord | 45 |
effector cells | 45 |
mosquito cells | 45 |
inflammatory response | 45 |
binding sites | 45 |
protein response | 45 |
host response | 45 |
rna levels | 44 |
viral fusion | 44 |
firefly luciferase | 44 |
capsid proteins | 44 |
highly pathogenic | 44 |
disease virus | 44 |
empty vector | 44 |
stranded dna | 44 |
mouse anti | 44 |
rta cells | 44 |
infected animals | 44 |
equine encephalitis | 44 |
previously shown | 44 |
i ifns | 44 |
forest virus | 44 |
specific cd | 44 |
well plate | 44 |
monoclonal antibodies | 44 |
results demonstrate | 43 |
wu virus | 43 |
viral rnas | 43 |
old world | 43 |
unfolded protein | 43 |
inhibitory effect | 43 |
applied biosystems | 43 |
infected cell | 43 |
nonstructural proteins | 43 |
di particle | 42 |
mhc class | 42 |
right panel | 42 |
reading frame | 42 |
zikv infection | 42 |
virus binding | 42 |
cut site | 42 |
template rna | 42 |
media containing | 42 |
gel electrophoresis | 42 |
barr virus | 42 |
transcription factors | 42 |
convalescent plasma | 42 |
semliki forest | 42 |
hek cells | 42 |
cell signaling | 42 |
i response | 41 |
initiation factor | 41 |
following infection | 41 |
veev capsid | 41 |
renilla luciferase | 41 |
ev infection | 41 |
antibody responses | 41 |
zika virus | 41 |
fold increase | 41 |
human coronavirus | 41 |
neutralizing antibody | 41 |
hcmv infection | 41 |
reverse genetics | 40 |
host immune | 40 |
luciferase reporter | 40 |
cleavage sites | 40 |
template rnas | 40 |
late domain | 40 |
recombinant viruses | 40 |
significant reduction | 40 |
way anova | 40 |
detected using | 40 |
binding rate | 40 |
side chain | 40 |
lymphocytic choriomeningitis | 40 |
growth factor | 40 |
statistical analysis | 39 |
replication cycle | 39 |
phylogenetic analysis | 39 |
fold change | 39 |
significant increase | 39 |
gene transcription | 39 |
buffer containing | 39 |
signaling pathways | 39 |
nonhuman primates | 39 |
hcv rna | 39 |
virus genome | 39 |
nlrp inflammasome | 39 |
infectious particles | 38 |
protein interactions | 38 |
fiber heads | 38 |
wt virus | 38 |
isg expression | 38 |
hong kong | 38 |
disease progression | 38 |
similar results | 38 |
virus strain | 38 |
active site | 38 |
lytic replication | 38 |
ctl escape | 38 |
replication proteins | 38 |
venezuelan equine | 38 |
viral genomic | 38 |
coronavirus spikes | 38 |
statistically significant | 38 |
results show | 38 |
pfu ml | 38 |
virus infected | 37 |
sense rna | 37 |
recent studies | 37 |
rna recombination | 37 |
farv votu | 37 |
coronavirus replication | 37 |
viral genes | 37 |
primary antibodies | 37 |
fetal bovine | 37 |
pro cells | 37 |
virus glycoprotein | 37 |
protease inhibitor | 37 |
cell receptor | 37 |
erk pathway | 37 |
data set | 36 |
induced apoptosis | 36 |
i interferons | 36 |
host rna | 36 |
western blots | 36 |
virus ns | 36 |
mm mgcl | 36 |
graphpad prism | 36 |
plasmacytoid dendritic | 36 |
fever virus | 36 |
cells transfected | 36 |
type virus | 36 |
host factor | 36 |
mhv replication | 36 |
secondary structure | 36 |
polyclonal anti | 35 |
protease inhibitors | 35 |
coding regions | 35 |
envelope glycoprotein | 35 |
immune activation | 35 |
choriomeningitis virus | 35 |
immune cells | 35 |
genomic rnas | 35 |
hiv infection | 35 |
veev cpd | 35 |
virus titer | 35 |
animal models | 35 |
confocal microscope | 35 |
surface area | 35 |
severe patients | 35 |
santa cruz | 35 |
protein interaction | 35 |
hendra virus | 35 |
sequence analysis | 35 |
left panel | 34 |
viral capsid | 34 |
deep sequencing | 34 |
ind entry | 34 |
cdna clones | 34 |
molecular weight | 34 |
protein complexes | 34 |
capsid phosphorylation | 34 |
pbs containing | 34 |
cells per | 34 |
replication complexes | 34 |
atpase activity | 34 |
activity towards | 34 |
antiviral responses | 34 |
cell activation | 34 |
time pcr | 34 |
alpha beta | 34 |
lipid mixing | 34 |
data demonstrate | 34 |
mutation frequencies | 34 |
small molecule | 34 |
stimulated gene | 34 |
animal care | 34 |
antiviral treatment | 33 |
lymph nodes | 33 |
marburg virus | 33 |
cell cultures | 33 |
buffered saline | 33 |
pfu cell | 33 |
thermo scientific | 33 |
supporting information | 33 |
mg kg | 33 |
virulence factors | 33 |
full length | 33 |
viral transcripts | 33 |
time course | 33 |
structural basis | 33 |
acid sequence | 33 |
sequence alignment | 33 |
purified using | 33 |
sox cut | 33 |
scale bar | 33 |
coding sequences | 33 |
infected macaques | 33 |
reading frames | 33 |
per cell | 33 |
following reovirus | 33 |
pr mtsin | 33 |
associated herpesvirus | 33 |
viral membrane | 33 |
wide range | 33 |
dna polymerase | 33 |
pcr using | 33 |
genome size | 33 |
indicated times | 33 |
ifitm cells | 33 |
significant difference | 32 |
late endosomes | 32 |
viral pathogenesis | 32 |
vsvdg zebovgp | 32 |
viral titer | 32 |
permissive temperature | 32 |
mouse igg | 32 |
whole cell | 32 |
regulatory factor | 32 |
rna species | 32 |
purified recombinant | 32 |
significantly lower | 32 |
fisher scientific | 32 |
helicase activity | 32 |
interferon response | 32 |
fusion conformation | 32 |
type ii | 32 |
rna genome | 32 |
tris ph | 32 |
alexa fluor | 32 |
heat shock | 32 |
hf cells | 31 |
generated using | 31 |
indicated time | 31 |
female mice | 31 |
site mutants | 31 |
ifn signaling | 31 |
human pathogens | 31 |
ifnar mice | 31 |
clinical signs | 31 |
reporter gene | 31 |
total number | 31 |
virus nonstructural | 31 |
one hour | 31 |
calculated using | 31 |
fluorescent protein | 31 |
cdna library | 31 |
rhesus macaques | 31 |
results showed | 31 |
virus families | 31 |
rabbit polyclonal | 31 |
emerging infectious | 31 |
virus stocks | 31 |
sequence data | 31 |
replication complex | 31 |
linked sias | 30 |
specific antibodies | 30 |
washed three | 30 |
viral loads | 30 |
mouth disease | 30 |
host protein | 30 |
rna remodeling | 30 |
transcriptional units | 30 |
host defense | 30 |
conformational change | 30 |
viral spread | 30 |
vitro transcribed | 30 |
plasmids encoding | 30 |
murine hepatitis | 30 |
brain stem | 30 |
pdb id | 30 |
encephalomyocarditis virus | 30 |
replication assay | 30 |
stimulated genes | 30 |
specific isgs | 30 |
biological replicates | 30 |
mosaic virus | 30 |
functional sbs | 30 |
higher levels | 30 |
negative strand | 30 |
ie expression | 30 |
may contribute | 30 |
binding proteins | 30 |
ribosome profiling | 30 |
initial binding | 30 |
fusion pore | 29 |
vdid dequenching | 29 |
ha na | 29 |
pi kb | 29 |
clinical trials | 29 |
dna viruses | 29 |
polysome association | 29 |
virus particle | 29 |
molecular basis | 29 |
cell membrane | 29 |
enzymatic activity | 29 |
acid residues | 29 |
rrv infection | 29 |
ev virus | 29 |
rna decay | 29 |
least three | 29 |
signal transduction | 29 |
human monoclonal | 29 |
particle production | 29 |
culture supernatant | 29 |
leukemia virus | 29 |
mhv infection | 29 |
containing mm | 29 |
even though | 29 |
virus evolution | 29 |
protein isgylation | 29 |
ns proteins | 29 |
ibv spike | 29 |
pr cam | 29 |
mrna expression | 29 |
previous reports | 29 |
reverse transcriptase | 28 |
cells stably | 28 |
agarose gel | 28 |
free virus | 28 |
cellular response | 28 |
nk cells | 28 |
rna chaperones | 28 |
specific antibody | 28 |
humoral responses | 28 |
class ii | 28 |
persistently infected | 28 |
helix unwinding | 28 |
virus inhibits | 28 |
acid synthesis | 28 |
cell cycle | 28 |
fold lower | 28 |
data show | 28 |
viral mrnas | 28 |
increased viral | 28 |
like particles | 28 |
mnv infection | 28 |
tested whether | 28 |
sequence identity | 28 |
family members | 28 |
significantly increased | 28 |
cell viability | 28 |
molecular mechanisms | 28 |
binding affinity | 28 |
virus capsid | 28 |
phylogenetic trees | 28 |
human erythrocytes | 28 |
fold dilutions | 28 |
progeny virions | 28 |
data sets | 28 |
transiently transfected | 27 |
serial dilutions | 27 |
tumv intercellular | 27 |
immune cell | 27 |
measles virus | 27 |
asymmetric unit | 27 |
uninfected cells | 27 |
vcp knockdown | 27 |
luciferase expression | 27 |
interferon regulatory | 27 |
read counts | 27 |
sybr green | 27 |
mouse monoclonal | 27 |
replication protein | 27 |
virus growth | 27 |
plant pathogens | 27 |
stably transduced | 27 |
using lipofectamine | 27 |
sox cleavage | 27 |
reactivated cells | 27 |
defective rna | 27 |
infected wt | 27 |
disease severity | 27 |
different genera | 27 |
heavy chain | 27 |
least two | 27 |
fold higher | 27 |
specific primers | 27 |
virus strains | 27 |
coding sequence | 27 |
like protein | 27 |
primary human | 27 |
cell extracts | 26 |
ex vivo | 26 |
eif aiii | 26 |
tomato bushy | 26 |
coronavirus infections | 26 |
cell lysis | 26 |
culture medium | 26 |
host gene | 26 |
bone marrow | 26 |
protein nsp | 26 |
reads mapping | 26 |
bushy stunt | 26 |
viral clearance | 26 |
using primers | 26 |
chronic hiv | 26 |
ravn gp | 26 |
human viruses | 26 |
previous study | 26 |
spinal cords | 26 |
rabies virus | 26 |
analysis revealed | 26 |
sinv replicase | 26 |
infectious hcv | 26 |
ifn response | 26 |
denv ns | 26 |
specific igg | 26 |
conjugated secondary | 26 |
stunt virus | 26 |
trizol reagent | 26 |
veev tc | 26 |
cellular factors | 26 |
severe covid | 26 |
virus fusion | 26 |
mini kit | 26 |
persistent infection | 26 |
inhibitor cocktail | 26 |
envelope protein | 26 |
previously identified | 26 |
apoptosis induction | 26 |
nuclear translocation | 26 |
gene transfer | 26 |
kshv lytic | 26 |
rna chaperone | 26 |
viral fh | 26 |
gene products | 26 |
human respiratory | 26 |
might also | 26 |
ev rna | 25 |
syndrome virus | 25 |
genome sequences | 25 |
times post | 25 |
murine cytomegalovirus | 25 |
growth medium | 25 |
virus release | 25 |
vp protein | 25 |
four hours | 25 |
negative controls | 25 |
dna sensing | 25 |
world bat | 25 |
minority variants | 25 |
immune evasion | 25 |
transcriptase complex | 25 |
measured using | 25 |
escape mutants | 25 |
type iii | 25 |
deficient mefs | 25 |
loading control | 25 |
cells well | 25 |
infectious disease | 25 |
distal ileum | 25 |
viral life | 25 |
directed mutagenesis | 25 |
thank dr | 25 |
virus hemagglutinin | 25 |
serum samples | 25 |
np cd | 25 |
apoptotic cells | 25 |
infectious clone | 25 |
sucrose cushion | 25 |
box helicases | 25 |
dominant negative | 25 |
recombinant virus | 25 |
os cells | 25 |
epithelial cell | 25 |
conjugated anti | 25 |
infected wild | 24 |
transcript levels | 24 |
using trizol | 24 |
host restriction | 24 |
reverse primer | 24 |
entry assay | 24 |
genome sequence | 24 |
cccdna synthesis | 24 |
sequencing data | 24 |
control samples | 24 |
cells via | 24 |
escherichia coli | 24 |
peripheral blood | 24 |
differentially expressed | 24 |
disease control | 24 |
light chain | 24 |
key role | 24 |
alphavirus replicases | 24 |
new host | 24 |
defective rnas | 24 |
bhk cells | 24 |
lower respiratory | 24 |
standard plaque | 24 |
sfv complex | 24 |
mm dtt | 24 |
sigma aldrich | 24 |
investigated whether | 24 |
house virus | 24 |
previously published | 24 |
molecular mechanism | 24 |
staphylococcus aureus | 24 |
sequence similarity | 24 |
atrh helicases | 24 |
mm kcl | 24 |
protein vp | 24 |
subcellular localization | 24 |
progeny particles | 24 |
viral control | 24 |
gp tmd | 24 |
replicase complex | 24 |
factor receptor | 24 |
severe disease | 24 |
beta interferon | 24 |
studies using | 24 |
receptor signaling | 24 |
significantly different | 24 |
cantell ld | 24 |
calf serum | 24 |
use committee | 24 |
cellular processes | 24 |
kshv rtcs | 24 |
cell monolayers | 24 |
consensus sequence | 24 |
zebov challenge | 24 |
flock house | 24 |
efficient replication | 24 |
confidence level | 24 |
spike glycoprotein | 24 |
particles per | 24 |
grey matter | 24 |
unpublished data | 24 |
viral growth | 24 |
clinical symptoms | 23 |
hsp inhibitors | 23 |
virus gene | 23 |
like domain | 23 |
dmem supplemented | 23 |
nucleocapsid protein | 23 |
cytokine signaling | 23 |
nucleic acids | 23 |
chikv infection | 23 |
san diego | 23 |
one day | 23 |
present study | 23 |
adaptive immunity | 23 |
takes place | 23 |
generation sequencing | 23 |
cell leukemia | 23 |
interferon alpha | 23 |
side chains | 23 |
results obtained | 23 |
bl mice | 23 |
rabbit igg | 23 |
single amino | 23 |
core structure | 23 |
necrosis factor | 23 |
electron density | 23 |
stress response | 23 |
two days | 23 |
mediated fusion | 23 |
proteolytic processing | 23 |
tbsv rna | 23 |
na balance | 23 |
gfp expression | 23 |
human influenza | 23 |
hcv particles | 23 |
ubiquitin ligase | 23 |
cell recognition | 23 |
quantitative pcr | 23 |
recombinant ded | 23 |
i loop | 23 |
low level | 23 |
yeast two | 23 |
lcmv di | 23 |
entry pathway | 23 |
host mrnas | 23 |
forming units | 23 |
primary antibody | 23 |
likely due | 23 |
plaque assays | 23 |
phosphorylated stat | 23 |
proteolytic cleavage | 23 |
life sciences | 23 |
newly synthesized | 23 |
bona fide | 22 |
unwinding activity | 22 |
cytopathic effect | 22 |
conserved among | 22 |
total protein | 22 |
mutator strains | 22 |
packaging signal | 22 |
rna template | 22 |
pcr product | 22 |
size exclusion | 22 |
standard curve | 22 |
large number | 22 |
means sd | 22 |
tumor necrosis | 22 |
seven days | 22 |
cdna libraries | 22 |
containing fbs | 22 |
dnase i | 22 |
ptx expression | 22 |
utero infection | 22 |
tgev rbd | 22 |
genome segments | 22 |
rna genomes | 22 |
may play | 22 |
results indicated | 22 |
ubiquitin ligases | 22 |
tombusvirus replication | 22 |
mock infected | 22 |
veev genome | 22 |
also found | 22 |
segment sequences | 22 |
complete genome | 22 |
mutant animals | 22 |
catalytic site | 22 |
cell populations | 22 |
protein level | 22 |
restriction factors | 22 |
determined whether | 22 |
receptor recognition | 22 |
utero zikv | 22 |
contains two | 22 |
many viruses | 22 |
using imagej | 22 |
binding specificity | 22 |
host genes | 22 |
lymph node | 22 |
embryonic fibroblasts | 22 |
provide evidence | 22 |
functional avidity | 22 |
adaptor protein | 22 |
human papillomavirus | 22 |
parainfluenza virus | 22 |
extracted using | 22 |
fatty acids | 22 |
african green | 22 |
complex formation | 22 |
orf ab | 21 |
incubated overnight | 21 |
proteins involved | 21 |
live virus | 21 |
regulated genes | 21 |
plasmid encoding | 21 |
institutional animal | 21 |
forward primer | 21 |
receptor balance | 21 |
cleavage product | 21 |
mediated restriction | 21 |
viral replicase | 21 |
vsv replication | 21 |
receptor density | 21 |
cantell hd | 21 |
also shown | 21 |
using anti | 21 |
ctl response | 21 |
cellular receptor | 21 |
quantitative rt | 21 |
foamy virus | 21 |
pcr amplification | 21 |
intracellular membranes | 21 |
culture supernatants | 21 |
better understand | 21 |
fusion peptide | 21 |
back dvgs | 21 |
restriction factor | 21 |
three days | 21 |
hours later | 21 |
least one | 21 |
pattern recognition | 21 |
dmem containing | 21 |
subgenomic mrna | 21 |
seq analysis | 21 |
rna degradation | 21 |
dna damage | 21 |
gut cd | 21 |
mean values | 21 |
virus spread | 21 |
infection may | 21 |
poorly understood | 21 |
recombinant mhv | 21 |
also known | 21 |
membrane proteins | 21 |
different species | 21 |
laboratory animals | 21 |
rlcmv wt | 21 |
envelope proteins | 21 |
compare lanes | 21 |
interfering particles | 21 |
ifitm proteins | 21 |
analysis using | 21 |
dn vps | 21 |
human samd | 21 |
myosin xi | 21 |
cell adhesion | 21 |
em structure | 21 |
mediated antiviral | 20 |
northern blot | 20 |
animal model | 20 |
evolutionary history | 20 |
attachment protein | 20 |
pandemic influenza | 20 |
ampk activation | 20 |
host interactions | 20 |
hydrogen bond | 20 |
virus attachment | 20 |
mice per | 20 |
like receptors | 20 |
golgi apparatus | 20 |
different viruses | 20 |
standard virus | 20 |
respiratory viruses | 20 |
hcl ph | 20 |
plasmids expressing | 20 |
fluorescence intensity | 20 |
antiviral signaling | 20 |
mice exhibited | 20 |
genbank accession | 20 |
serological assays | 20 |
virus envelope | 20 |
interferon responses | 20 |
affinity purified | 20 |
late domains | 20 |
tyrosine kinase | 20 |
norovirus infection | 20 |
terminal region | 20 |
high level | 20 |
molecular replacement | 20 |
copy number | 20 |
viral polymerase | 20 |
subgenomic rna | 20 |
replication sites | 20 |
binding properties | 20 |
kind gift | 20 |
virus transmission | 20 |
loaded onto | 20 |
mm sodium | 20 |
cell survival | 20 |
virus nsp | 20 |
host shifts | 20 |
effector functions | 20 |
particle release | 20 |
bat influenza | 20 |
capsid assembly | 20 |
tfr orthologs | 20 |
bars represent | 20 |
mrna cap | 20 |
cypa cells | 20 |
blood plasma | 20 |
data collection | 20 |
antigenic site | 20 |
membrane vesicles | 20 |
cd ko | 20 |
stop codon | 20 |
may provide | 20 |
crystal violet | 20 |
ev vp | 20 |
expression vector | 20 |
mutation rates | 20 |
target proteins | 20 |
innate antiviral | 20 |
untranslated region | 20 |
vesicular transport | 20 |
cellular membranes | 20 |
tcr recognition | 20 |
reduced viral | 20 |
btv wt | 20 |
distantly related | 20 |
expression plasmids | 20 |
ripa buffer | 20 |
allowed us | 19 |
sg promoter | 19 |
infectious peritonitis | 19 |
virulence factor | 19 |
real time | 19 |
cho cells | 19 |
high affinity | 19 |
shock protein | 19 |
high moi | 19 |
viral antigen | 19 |
antiviral therapy | 19 |
antibodies specific | 19 |
neutralization activities | 19 |
national institutes | 19 |
entry pathways | 19 |
mass spectrometry | 19 |
days later | 19 |
airway epithelial | 19 |
mapped reads | 19 |
whole genome | 19 |
mammalian species | 19 |
mcmv genome | 19 |
using standard | 19 |
mn ss | 19 |
infected ips | 19 |
receptor specificity | 19 |
serial passage | 19 |
data showed | 19 |
viral population | 19 |
immune signaling | 19 |
cgas expression | 19 |
ifitm overexpression | 19 |
productive infection | 19 |
specific inhibitor | 19 |
selective pressure | 19 |
nuclear pore | 19 |
serum albumin | 19 |
mouse lungs | 19 |
wsn hamtsin | 19 |
blood group | 19 |
using flow | 19 |
stably expressing | 19 |
na proteins | 19 |
rna helix | 19 |
less efficient | 19 |
standard infectious | 19 |
polyacrylamide gel | 19 |
yeast strain | 19 |
quantified using | 19 |
positive control | 19 |
viral escape | 19 |
virulence gene | 19 |
japanese encephalitis | 19 |
mediated endocytosis | 19 |
phosphorylation sites | 19 |
data support | 19 |
particle formation | 19 |
clinical disease | 19 |
iav particles | 19 |
lipid metabolism | 19 |
positively charged | 19 |
packaging signals | 19 |
image analysis | 19 |
future studies | 19 |
linear model | 19 |
expression profiles | 19 |
plate reader | 19 |
fetal calf | 19 |
entry step | 19 |
significant decrease | 19 |
family proteins | 19 |
binding assay | 19 |
viruses may | 19 |
complementation group | 19 |
bat iavs | 19 |
cd cd | 19 |
binding region | 19 |
feline infectious | 19 |
early stages | 19 |
vectors expressing | 19 |
isolated using | 19 |
gp tm | 18 |
river virus | 18 |
rdrp initiation | 18 |
specific iga | 18 |
porcine reproductive | 18 |
influenza hemagglutinin | 18 |
cells compared | 18 |
later time | 18 |
green monkey | 18 |
fusion pores | 18 |
virus movement | 18 |
host responses | 18 |
investigate whether | 18 |
deisgylase dub | 18 |
lower levels | 18 |
genital mucosa | 18 |
structural features | 18 |
primers used | 18 |
noncoding rna | 18 |
acute infection | 18 |
monoclonal anti | 18 |
gene induction | 18 |
phylogenetic tree | 18 |
host innate | 18 |
first step | 18 |
rna products | 18 |
tissue damage | 18 |
luciferase assay | 18 |
conjugated goat | 18 |
flavivirus ns | 18 |
enter cells | 18 |
accession numbers | 18 |
hcv replication | 18 |
lentiviral vectors | 18 |
quadricep muscles | 18 |
virus vp | 18 |
arachidonic acid | 18 |
ppxy late | 18 |
mice sacrificed | 18 |
human genome | 18 |
ross river | 18 |
seq data | 18 |
vaccine development | 18 |
virus assembly | 18 |
serially diluted | 18 |
escrt pathway | 18 |
different cell | 18 |
test whether | 18 |
altered peptide | 18 |
ko cells | 18 |
hr post | 18 |
ifn induction | 18 |
mice lacking | 18 |
cold pbs | 18 |
relatively low | 18 |
may explain | 18 |
fibrinogen deposition | 18 |
horseradish peroxidase | 18 |
lung epithelial | 18 |
obtained using | 18 |
viral translation | 18 |
cells lacking | 18 |
hrs post | 18 |
tmprss knock | 18 |
lpin mrna | 18 |
virus disease | 18 |
two distinct | 18 |
wsn wt | 18 |
single nucleotide | 18 |
world alphaviruses | 18 |
cellular mrna | 18 |
unfolded proteins | 18 |
without affecting | 18 |
transcriptional activation | 18 |
novel coronavirus | 18 |
transmissible gastroenteritis | 18 |
intracellular trafficking | 18 |
replication defects | 18 |
replicase proteins | 18 |
mice compared | 18 |
tlr responses | 18 |
linear regression | 18 |
immediate early | 18 |
increased levels | 18 |
knockdown cells | 18 |
lr cells | 18 |
untreated cells | 18 |
sequence reads | 18 |
acid sequences | 18 |
qybv votu | 17 |
technical assistance | 17 |
human disease | 17 |
expression vectors | 17 |
raw data | 17 |
histocompatibility complex | 17 |
core isgs | 17 |
elevated levels | 17 |
facs analysis | 17 |
functional analysis | 17 |
fruit bats | 17 |
cellular pathways | 17 |
first time | 17 |
asked whether | 17 |
lipid droplets | 17 |
valley fever | 17 |
using two | 17 |
electrostatic interactions | 17 |
comparative analysis | 17 |
antiviral activities | 17 |
cathepsin activity | 17 |
affected offspring | 17 |
yeast cells | 17 |
new england | 17 |
functional receptor | 17 |
total volume | 17 |
higher level | 17 |
novel host | 17 |
virus proteins | 17 |
response via | 17 |
mortality rates | 17 |
helpful discussions | 17 |
protein sequence | 17 |
antiviral defense | 17 |
hpiv infection | 17 |
denv infection | 17 |
expression level | 17 |
mediated inhibition | 17 |
electron microscope | 17 |
replicase complexes | 17 |
secondary structures | 17 |
ifn receptor | 17 |
infected macrophages | 17 |
reaction buffer | 17 |
derived macrophages | 17 |
constructed using | 17 |
assay using | 17 |
green fluorescent | 17 |
several viruses | 17 |
efficient viral | 17 |
data analysis | 17 |
late time | 17 |
viral genotypes | 17 |
endothelial cells | 17 |
iii ifns | 17 |
mechanisms underlying | 17 |
new insights | 17 |
chronic hepatitis | 17 |
sequence alignments | 17 |
proteins may | 17 |
significantly decreased | 17 |
medium supplemented | 17 |
previous work | 17 |
host shutoff | 17 |
rna editing | 17 |
transcriptional unit | 17 |
progeny virus | 17 |
increasing amounts | 17 |
associated protein | 17 |
structural analysis | 17 |
major histocompatibility | 17 |
transmembrane protein | 17 |
adhesion molecule | 17 |
reovirus replication | 17 |
golgi complex | 17 |
cellular gene | 17 |
strong evidence | 17 |
interferon signaling | 17 |
day pi | 17 |
rna accumulation | 17 |
group viruses | 17 |
papn ectodomain | 17 |
facs buffer | 17 |
fusion hmpv | 17 |
crystal forms | 17 |
nucleotide position | 17 |
oas rnase | 17 |
recent study | 17 |
two viruses | 17 |
respiratory distress | 17 |
prion protein | 17 |
bid cleavage | 17 |
throughput sequencing | 17 |
experimental conditions | 17 |
imagej software | 17 |
two major | 17 |
peptide ligand | 17 |
hcmv growth | 17 |
assay system | 17 |
nitrocellulose membranes | 17 |
cell wall | 17 |
infected rl | 17 |
antibody response | 17 |
fgl expression | 17 |
gp lp | 17 |
different host | 17 |
virus concentration | 17 |
sepharose beads | 17 |
mers coronavirus | 17 |
liquid nitrogen | 17 |
mediated activation | 17 |
passage series | 17 |
receptor interactions | 17 |
specific infectivity | 17 |
structural changes | 17 |
rna templates | 17 |
tract infections | 17 |
functional domains | 16 |
use human | 16 |
cov entry | 16 |
type infection | 16 |
simian immunodeficiency | 16 |
purified tombusvirus | 16 |
btv unag | 16 |
infection cycle | 16 |
ie transcript | 16 |
master mix | 16 |
host jumping | 16 |
spliced transcripts | 16 |
plos pathogens | 16 |
kd cells | 16 |
downstream effectors | 16 |
proinflammatory cytokines | 16 |
cytometry analysis | 16 |
inducible gene | 16 |
density maps | 16 |
protein inhibits | 16 |
mcmv infection | 16 |
log likelihood | 16 |
tcid mouse | 16 |
recognition receptors | 16 |
specific shrna | 16 |
human lung | 16 |
inhibits dna | 16 |
four days | 16 |
also possible | 16 |
ev entry | 16 |
also revealed | 16 |
total cellular | 16 |
virus budding | 16 |
car expression | 16 |
virus family | 16 |
dna synthesis | 16 |
column buffer | 16 |
gp furin | 16 |
inflammatory cytokines | 16 |
different time | 16 |
structural elements | 16 |
protein ns | 16 |
containing fcs | 16 |
sinv template | 16 |
rna fragments | 16 |
particles produced | 16 |
data provide | 16 |
cell lysate | 16 |
antigenic sites | 16 |
also detected | 16 |
studies revealed | 16 |
optical density | 16 |
virus challenge | 16 |
binding domains | 16 |
translational control | 16 |
viruses containing | 16 |
rna elements | 16 |
essential medium | 16 |
transposon insertions | 16 |
plasmid expressing | 16 |
well known | 16 |
viral envelope | 16 |
data presented | 16 |
polymerase ii | 16 |
degrading cgas | 16 |
parental virus | 16 |
mtase mutant | 16 |
mouse lung | 16 |
rna structures | 16 |
termination codon | 16 |
vitro transcription | 16 |
inflammatory monocytes | 16 |
also showed | 16 |
infect cells | 16 |
gb virus | 16 |
modified bat | 16 |
entry route | 16 |
next day | 16 |
two additional | 16 |
oxidative stress | 16 |
much less | 16 |
polymerase activity | 16 |
linked glycans | 16 |
findings suggest | 16 |
small rna | 16 |
nh cl | 16 |
rna interference | 16 |
increased susceptibility | 16 |
humidified incubator | 16 |
viral infectivity | 16 |
tlr signaling | 16 |
ww domain | 16 |
signaling cascade | 16 |
infection using | 16 |
protein folding | 16 |
receptor tyrosine | 16 |
analysis showed | 16 |
recombinant human | 16 |
sirna transfection | 16 |
lesser extent | 16 |
expressing gfp | 16 |
specific binding | 16 |
direct interaction | 16 |
confocal images | 16 |
genome segment | 16 |
described earlier | 16 |
isg conjugates | 16 |
selection pressure | 16 |
sensitive mutants | 16 |
mixing test | 16 |
reverse transcribed | 16 |
vector control | 16 |
molecule inhibitors | 16 |
hcmv replication | 16 |
sting pathway | 16 |
free medium | 16 |
interferon stimulated | 16 |
major role | 16 |
rna extraction | 16 |
hydrogen bonds | 16 |
rift valley | 16 |
may reflect | 16 |
sialic acids | 16 |
acute phase | 16 |
chaperone activity | 16 |
virus egress | 16 |
euthanasia criteria | 16 |
enveloped virus | 16 |
length distributions | 16 |
virus pools | 15 |
single virus | 15 |
deficient macrophages | 15 |
genes involved | 15 |
expression plasmid | 15 |
human cell | 15 |
multiple comparisons | 15 |
mononuclear cells | 15 |
env tmd | 15 |
donkey anti | 15 |
current study | 15 |
cellular immune | 15 |
blot using | 15 |
ae albopictus | 15 |
growth kinetics | 15 |
one representative | 15 |
antiviral drugs | 15 |
studies suggest | 15 |
cleaved gp | 15 |
antibody titers | 15 |
pl pro | 15 |
laboratory animal | 15 |
prepared using | 15 |
replicase protein | 15 |
biological processes | 15 |
strongly reduced | 15 |
broadly neutralizing | 15 |
iav ha | 15 |
visualized using | 15 |
blocking buffer | 15 |
target genes | 15 |
cells grown | 15 |
erk signaling | 15 |
bars indicate | 15 |
cytosolic dna | 15 |
viral disease | 15 |
emerging viruses | 15 |
sample buffer | 15 |
crystal form | 15 |
cell counts | 15 |
ts mutant | 15 |
fidelity variants | 15 |
coxsackie virus | 15 |
fold less | 15 |
genomic dna | 15 |
per se | 15 |
positive strand | 15 |
multiple sequence | 15 |
three different | 15 |
molecule inhibitor | 15 |
promote viral | 15 |
human population | 15 |
cells may | 15 |
yeast dbp | 15 |
among different | 15 |
tombusvirus rna | 15 |
mouse samd | 15 |
point mutations | 15 |
immune recognition | 15 |
following day | 15 |
transcribed rna | 15 |
membrane association | 15 |
protein translation | 15 |
pdb code | 15 |
lung tissues | 15 |
error bar | 15 |
acid biosynthesis | 15 |
total virus | 15 |
isg transcription | 15 |
using graphpad | 15 |
virus genomes | 15 |
ev virions | 15 |
viral species | 15 |
marv ravn | 15 |
may occur | 15 |
mouse cells | 15 |
expression data | 15 |
exclusion chromatography | 15 |
host switching | 15 |
btv ns | 15 |
antiviral cd | 15 |
mouse embryonic | 15 |
molecular patterns | 15 |
study provides | 15 |
mutant mice | 15 |
promoter region | 15 |
viral particle | 15 |
sites identified | 15 |
ectopic expression | 15 |
vitro studies | 15 |
reference genome | 15 |
viral sequences | 15 |
gene segments | 15 |
assays using | 15 |
mice showed | 15 |
infectious vsv | 15 |
also used | 15 |
cdna synthesis | 15 |
animal studies | 15 |
experiments using | 15 |
differential expression | 15 |
gene ontology | 15 |
viral transcription | 15 |
host co | 15 |
replication kinetics | 15 |
cell imaging | 15 |
induced gene | 15 |
four serotypes | 15 |
replication compartments | 15 |
hepes ph | 15 |
associated gene | 15 |
sodium dodecyl | 15 |
molecular biology | 15 |
gaussia luciferase | 15 |
gluc expression | 15 |
mitochondrial membrane | 15 |
virus host | 15 |
england biolabs | 15 |
infectivity titers | 15 |
dependent signaling | 15 |
ie protein | 15 |
mediated cell | 15 |
membrane protein | 15 |
expression analysis | 15 |
processed using | 15 |
strand templates | 15 |
early secretory | 15 |
dna sequencing | 15 |
human antibody | 15 |
ifn responses | 15 |
ag mice | 15 |
monomeric hmpv | 15 |
nanopore sequencing | 15 |
dodecyl sulfate | 15 |
np protein | 15 |
three mice | 15 |
human igg | 15 |
data also | 15 |
gp wing | 15 |
situ hybridization | 15 |
ml penicillin | 15 |
close proximity | 15 |
blood samples | 15 |
quaternary packing | 15 |
early phase | 15 |
apoptotic pathway | 15 |
ha proteins | 15 |
structural studies | 15 |
goat serum | 15 |
total cytoplasmic | 15 |
recently shown | 15 |
control mice | 15 |
virion release | 15 |
nuclear factor | 14 |
potential role | 14 |
mode interface | 14 |
productive cycle | 14 |
novel viruses | 14 |
state university | 14 |
signal transducer | 14 |
af mab | 14 |
cell spread | 14 |
total cell | 14 |
mapk pathway | 14 |
much lower | 14 |
analysed using | 14 |
site mutant | 14 |
viral fitness | 14 |
containing protein | 14 |
equal amounts | 14 |
receptor usage | 14 |
mhv pseudoviruses | 14 |
metabolic rate | 14 |
cruz biotechnology | 14 |
ribosomal frameshifting | 14 |
defective viral | 14 |
human host | 14 |
soil minerals | 14 |
protein lysates | 14 |
inflammatory diseases | 14 |
type cells | 14 |
assay kit | 14 |
foster city | 14 |
vector cells | 14 |
pathogenic viruses | 14 |
protein sequences | 14 |
purified rsv | 14 |
heat map | 14 |
marv gp | 14 |
vaccine design | 14 |
capsid disassembly | 14 |
box rna | 14 |
prism software | 14 |
immune defenses | 14 |
drug concentrations | 14 |
influenza infection | 14 |
animal experiments | 14 |
rna polymerases | 14 |
cellular genes | 14 |
pathogen interactions | 14 |
infectious evs | 14 |
based therapies | 14 |
alphaviral infection | 14 |
length hpiv | 14 |
free isg | 14 |
nucleotide sequence | 14 |
tyrosine kinases | 14 |
also performed | 14 |
live attenuated | 14 |
transfected hek | 14 |
quality control | 14 |
particle assembly | 14 |
ampka ampka | 14 |
protective immunity | 14 |
may facilitate | 14 |
inoculated mice | 14 |
reaction mixture | 14 |
translation inhibition | 14 |
infection efficiency | 14 |
next determined | 14 |
isg aa | 14 |
phosphatase activity | 14 |
cultured cells | 14 |
hr later | 14 |
replication assays | 14 |
signal peptide | 14 |
mrna decay | 14 |
ligand vaccination | 14 |
sa protein | 14 |
pcr primers | 14 |
nuclear export | 14 |
increasing concentrations | 14 |
associated reads | 14 |
pore formation | 14 |
spike proteins | 14 |
human airway | 14 |
top row | 14 |
remains unclear | 14 |
target cell | 14 |
using different | 14 |
reporter assay | 14 |
protein stability | 14 |
essential amino | 14 |
early stage | 14 |
similar levels | 14 |
per group | 14 |
infectious bronchitis | 14 |
neuronal cells | 14 |
translation elongation | 14 |
two residues | 14 |
pcr assays | 14 |
single cell | 14 |
rna using | 14 |
membrane structures | 14 |
rate limiting | 14 |
albopictus cells | 14 |
virus isolates | 14 |
hr pi | 14 |
isg conjugation | 14 |
dep entry | 14 |
polyclonal antibody | 14 |
high titers | 14 |
will likely | 14 |
nw arenaviruses | 14 |
resistant viruses | 14 |
replication efficiency | 14 |
via proline | 14 |
unknown function | 14 |
pneumovirus fusion | 14 |
genetic analysis | 14 |
ml streptomycin | 14 |
spike ectodomain | 14 |
associated virus | 14 |
associated molecular | 14 |
positive selection | 14 |
ctl responses | 14 |
may represent | 14 |
recent work | 14 |
cells overexpressing | 14 |
fold serial | 14 |
maximum likelihood | 14 |
vesicular egress | 14 |
related viruses | 14 |
plasmids containing | 14 |
start codon | 14 |
min ph | 14 |
sheep cells | 14 |
ub activity | 14 |
chikv template | 14 |
currently available | 14 |
tagv votu | 14 |
ab therapies | 14 |
zoonotic transmission | 14 |
virus replicase | 14 |
mammalian hosts | 14 |
intergenic regions | 14 |
rnai screen | 14 |
dotted line | 14 |
central role | 14 |
acidic ph | 14 |
also investigated | 14 |
washed times | 14 |
emcv ros | 14 |
negative strands | 14 |
oligoadenylate synthetase | 14 |
ntc depletion | 14 |
loading buffer | 14 |
house elisa | 14 |
rodent species | 14 |
retroviral vectors | 14 |
plaque forming | 14 |
i expression | 14 |
mice immunized | 14 |
tuning antiviral | 14 |
antiviral protein | 14 |
binding pocket | 14 |
binding curves | 14 |
acid substitution | 14 |
infection results | 14 |
expression using | 14 |
monitored daily | 14 |
inflammasome activation | 14 |
respiratory disease | 14 |
insect cells | 14 |
converting enzyme | 14 |
recently reported | 14 |
denv diii | 14 |
dengue vaccine | 14 |
luciferase gene | 14 |
previously demonstrated | 14 |
minimal essential | 13 |
reported previously | 13 |
specific peaks | 13 |
antiviral effect | 13 |
tcr binding | 13 |
tcr repertoire | 13 |
greatly reduced | 13 |
diffraction data | 13 |
host translation | 13 |
endosomal membrane | 13 |
gene duplication | 13 |
cytoplasmic fraction | 13 |
massively parallel | 13 |
mitochondrial apoptosis | 13 |
ampka mefs | 13 |
library preparation | 13 |
dgkv votu | 13 |
crucial role | 13 |
treated samples | 13 |
studies will | 13 |
multiple roles | 13 |
virus induces | 13 |
genetic material | 13 |
neutralizing activities | 13 |
ring finger | 13 |
length distribution | 13 |
protein concentration | 13 |
fusion process | 13 |
unreactivated cells | 13 |
hbv dna | 13 |
days pos | 13 |
signaling protein | 13 |
mediator complex | 13 |
free conditions | 13 |
genome expansion | 13 |
ifn suppression | 13 |
reticulum stress | 13 |
data point | 13 |
infectious viral | 13 |
lysine residues | 13 |
viruses also | 13 |
gene product | 13 |
human foreskin | 13 |
cell supernatants | 13 |
factors involved | 13 |
viral strains | 13 |
protein genes | 13 |
pro correlates | 13 |
hepatitis coronavirus | 13 |
car binding | 13 |
antiviral immunity | 13 |
humoral immune | 13 |
modified eagle | 13 |
significantly less | 13 |
translational regulation | 13 |
biosafety level | 13 |
recombinant protein | 13 |
cells showed | 13 |
plasmid containing | 13 |
single stranded | 13 |
ms ms | 13 |
pathogenic avian | 13 |
also identified | 13 |
rhtrs replication | 13 |
nsp protein | 13 |
three copies | 13 |
red blood | 13 |
infection experiments | 13 |
culture media | 13 |
new virus | 13 |
standard deviations | 13 |
density map | 13 |
cells co | 13 |
fhv rna | 13 |
may affect | 13 |
human infection | 13 |
blood cells | 13 |
tissue tropism | 13 |
bal fluid | 13 |
enteroviral rna | 13 |
rna sequencing | 13 |
cause disease | 13 |
ppxy motifs | 13 |
represent mean | 13 |
escrt machinery | 13 |
nuclear localization | 13 |
vector alone | 13 |
recently identified | 13 |
coronavirus nsp | 13 |
cellular functions | 13 |
mammalian cell | 13 |
highly specific | 13 |
virus released | 13 |
blot hybridization | 13 |
disease emergence | 13 |
capillary electrophoresis | 13 |
identified using | 13 |
analysis software | 13 |
like viruses | 13 |
mucus layer | 13 |
guanine nucleotide | 13 |
bronchial epithelial | 13 |
also demonstrated | 13 |
adenovirus type | 13 |
bluetongue virus | 13 |
mucosal hiv | 13 |
protein accumulation | 13 |
plaque formation | 13 |
sting signaling | 13 |
cell tropism | 13 |
containing either | 13 |
secretory lysosomes | 13 |
control shrna | 13 |
metabolic labeling | 13 |
neutral ph | 13 |
antiviral state | 13 |
data obtained | 13 |
protein complex | 13 |
ml pbs | 13 |
study also | 13 |
model system | 13 |
cellular transcription | 13 |
trimer interface | 13 |
infectious cdna | 13 |
penton base | 13 |
mrna degradation | 13 |
rneasy mini | 13 |
highly sensitive | 13 |
differentially regulated | 13 |
transmembrane domain | 13 |
lipin silencing | 13 |
iav fusion | 13 |
human health | 13 |
pfv env | 13 |
eukaryotic initiation | 13 |
ca atoms | 13 |
remains unknown | 13 |
several studies | 13 |
pcr kit | 13 |
expressed genes | 13 |
left untreated | 13 |
gfp reporter | 13 |
cell pellets | 13 |
rna transcripts | 13 |
intranasal infection | 13 |
infectious particle | 13 |
novel spliced | 13 |
see materials | 13 |
recent years | 13 |
host cellular | 13 |
cellular helicases | 13 |
escape variants | 13 |
quantitative real | 13 |
additional transcriptional | 13 |
data represent | 13 |
induced stat | 13 |
mediated gene | 13 |
wt mhv | 13 |
naturally occurring | 13 |
infected rd | 13 |
cortical neurons | 13 |
competing interests | 13 |
qualitative differences | 13 |
control group | 13 |
independent replicates | 13 |
confidence intervals | 13 |
genome sequencing | 13 |
viruses isolated | 13 |
vaccine candidates | 13 |
iga responses | 13 |
biolayer interferometry | 13 |
knockout mice | 13 |
nonhuman primate | 13 |
induced protein | 13 |
sox targeting | 13 |
cynomolgus macaques | 13 |
rnaseq density | 13 |
using antibodies | 13 |
reactive oxygen | 13 |
molecular mass | 13 |
negative feedback | 13 |
also determined | 13 |
bat virus | 13 |
leader sequence | 13 |
start site | 13 |
mouse models | 13 |
also thank | 13 |
homologous recombination | 13 |
extracellular vesicles | 13 |
pfu rrv | 13 |
clinical score | 13 |
protease activity | 13 |
denaturing gel | 12 |
like virus | 12 |
using relion | 12 |
tmd peptide | 12 |
trimeric hmpv | 12 |
entry factors | 12 |
saudi arabia | 12 |
affect viral | 12 |
ph pulse | 12 |
viral pathogens | 12 |
ki virus | 12 |
gene silencing | 12 |
prompted us | 12 |
first line | 12 |
culture systems | 12 |
internal protein | 12 |
cchfv votu | 12 |
species barrier | 12 |
greater jakarta | 12 |
tegument protein | 12 |
deisgylase activity | 12 |
virus pathogenesis | 12 |
pore complex | 12 |
eagle medium | 12 |
using specific | 12 |
epidermal growth | 12 |
plasma drug | 12 |
competition assay | 12 |
labeled rna | 12 |
intracellular compartments | 12 |
may indicate | 12 |
segment tree | 12 |
mediated apoptosis | 12 |
rhtrs locus | 12 |
guinea pigs | 12 |
specific genes | 12 |
accession number | 12 |
hela cell | 12 |
specific igm | 12 |
necrosis virus | 12 |
free dmem | 12 |
death receptors | 12 |
orf vrps | 12 |
previously observed | 12 |
ribosomal pausing | 12 |
ultrasensitive response | 12 |
tail tube | 12 |
cleavage activation | 12 |
tail fiber | 12 |
protein production | 12 |
using rna | 12 |
also significantly | 12 |
infectious progeny | 12 |
box helicase | 12 |
apoptosis induced | 12 |
viral polyprotein | 12 |
endocytic pathways | 12 |
efficiently used | 12 |
ifnb mrna | 12 |
immunofluorescence staining | 12 |
antiviral effects | 12 |
sanger sequencing | 12 |
mice following | 12 |
stat signaling | 12 |
transgenic mice | 12 |
top panel | 12 |
species tropism | 12 |
human parainfluenza | 12 |
per sample | 12 |
mediated membrane | 12 |
isg mutants | 12 |
unless otherwise | 12 |
vertebrate hosts | 12 |
less efficiently | 12 |
virus variants | 12 |
dendritic cell | 12 |
human transmission | 12 |
nuclear bodies | 12 |
golgi network | 12 |
type culture | 12 |
catalytic activity | 12 |
newcastle disease | 12 |
box proteins | 12 |
interferon production | 12 |
inhibitor concentrations | 12 |
two proteins | 12 |
line represents | 12 |
mhv rna | 12 |
norwalk virus | 12 |
provide new | 12 |
mean fluorescence | 12 |
gene family | 12 |
relatively high | 12 |
signaling cascades | 12 |
factors required | 12 |
mode conformation | 12 |
triphosphate rna | 12 |
rna stability | 12 |
viral rtcs | 12 |
ppxy domain | 12 |
entry receptor | 12 |
contained within | 12 |
virus neuraminidase | 12 |
coronavirus papain | 12 |
using either | 12 |
live cell | 12 |
cyclophilin inhibitors | 12 |
proteasomal degradation | 12 |
replication defect | 12 |
ifn treatment | 12 |
jak stat | 12 |
world arenaviruses | 12 |
virion dna | 12 |
rna secondary | 12 |
constitutively expressed | 12 |
six replicates | 12 |
pivotal role | 12 |
early time | 12 |
mrna mrna | 12 |
proteins encoded | 12 |
significant role | 12 |
infected individuals | 12 |
tissue samples | 12 |
tlr tmd | 12 |
acid substitutions | 12 |
also consistent | 12 |
synthetic glycans | 12 |
strongly suggest | 12 |
immune surveillance | 12 |
critical roles | 12 |
coronavirus rna | 12 |
host helicases | 12 |
also affect | 12 |
interfering rnas | 12 |
associated coronavirus | 12 |
parallel sequencing | 12 |
inflammatory responses | 12 |
binding motif | 12 |
neutralizing human | 12 |
surface expression | 12 |
nsp residues | 12 |
pcr reactions | 12 |
rhtrs amplification | 12 |
analysis also | 12 |
fusion mediated | 12 |
pfu per | 12 |
reduced levels | 12 |
spliced transcript | 12 |
igg antibodies | 12 |
new human | 12 |
cell membranes | 12 |
international committee | 12 |
survival time | 12 |
rna isolated | 12 |
sequencing reads | 12 |
interfering rna | 12 |
feline coronavirus | 12 |
hh hn | 12 |
rhesus monkeys | 12 |
i digestion | 12 |
poliovirus rna | 12 |
thermofisher scientific | 12 |
next generation | 12 |
primer pairs | 12 |
gastroenteritis virus | 12 |
emerging infections | 12 |
low dose | 12 |
may result | 12 |
mice died | 12 |
drosophila melanogaster | 12 |
containing galactose | 12 |
studies indicate | 12 |
viral factors | 12 |
van der | 12 |
hbv infection | 12 |
negative regulator | 12 |
ec value | 12 |
negative mutant | 12 |
culture collection | 12 |
data using | 12 |
recombinant proteins | 12 |
gradient centrifugation | 12 |
subgenomic mrnas | 12 |
lentiviral vector | 12 |
case fatality | 12 |
buried surface | 12 |
depleted cells | 12 |
restriction sites | 12 |
rna interactions | 12 |
viral ns | 12 |
fusion state | 12 |
protein trimer | 12 |
translation efficiency | 12 |
cccdna formation | 12 |
high throughput | 12 |
cell debris | 12 |
american type | 12 |
riboseq chx | 12 |
flow cytometer | 12 |
growth curves | 12 |
relatively small | 12 |
coronavirus entry | 12 |
complete medium | 12 |
uninfected controls | 12 |
antibody recognition | 12 |
lytic infection | 12 |
ip assays | 12 |
recombination event | 12 |
alternative splicing | 12 |
cns pathology | 12 |
much higher | 12 |
performed according | 12 |
antiviral action | 12 |
long pentraxin | 12 |
ray diffraction | 12 |
nitrocellulose membrane | 12 |
productive virus | 12 |
functional receptors | 12 |
convalescent sera | 12 |
lg ml | 12 |
eukaryotically expressed | 12 |
results provide | 12 |
enhanced viral | 12 |
interferon induction | 12 |
important human | 12 |
natural reservoir | 12 |
chikv nsp | 12 |
like proteases | 12 |
viral promoters | 12 |
charged residues | 12 |
viral attachment | 12 |
plasmid dna | 12 |
transduced cells | 12 |
danger signals | 12 |
endocytic pathway | 12 |
serial passaging | 12 |
prcv rbd | 12 |
molecular graphics | 12 |
mb tif | 12 |
complex class | 12 |
uv light | 12 |
primary manuscript | 12 |
cytomegalovirus infection | 12 |
nt surrounding | 12 |
wide variety | 12 |
mature di | 12 |
domain complexed | 12 |
reads per | 12 |
superscript iii | 11 |
following inoculation | 11 |
human bronchial | 11 |
liver disease | 11 |
human primates | 11 |
apoptotic cell | 11 |
via plaque | 11 |
cell movement | 11 |
sars patients | 11 |
encode proteins | 11 |
replicase assay | 11 |
replication occurs | 11 |
also reduced | 11 |
reproductive number | 11 |
two hours | 11 |
recombinant ibv | 11 |
via sds | 11 |
adenovirus vectors | 11 |
human embryonic | 11 |
multivesicular bodies | 11 |
induce apoptosis | 11 |
wt controls | 11 |
deficient coronaviruses | 11 |
ectopically expressed | 11 |
four denv | 11 |
climate change | 11 |
lipin expression | 11 |
cleavage degradation | 11 |
genes encoding | 11 |
cord grey | 11 |
previous report | 11 |
significant effect | 11 |
plasma therapy | 11 |
one another | 11 |
aug codon | 11 |
mediated induction | 11 |
examined whether | 11 |
reaction mixtures | 11 |
rna mini | 11 |
coronavirus endou | 11 |
analysis tools | 11 |
respiratory infections | 11 |
infected epithelial | 11 |
fhv replicase | 11 |
shed light | 11 |
ub substrates | 11 |
structural model | 11 |
ifnar signaling | 11 |
findings indicate | 11 |
genome using | 11 |
virus mutant | 11 |
recognition receptor | 11 |
internal control | 11 |
currently unknown | 11 |
transfection cells | 11 |
trend toward | 11 |
apoptosis via | 11 |
significantly enhanced | 11 |
see table | 11 |
isgylation assays | 11 |
pan rna | 11 |
either directly | 11 |
nairoviridae family | 11 |
ha protein | 11 |
almost identical | 11 |
one way | 11 |
cell proliferation | 11 |
nm bafa | 11 |
specific mabs | 11 |
surface protein | 11 |
mitochondrial apoptotic | 11 |
proteolytic activation | 11 |
cd mice | 11 |
recombinant sars | 11 |
nt upstream | 11 |
transfected using | 11 |
see also | 11 |
coronavirus hku | 11 |
nedd ligases | 11 |
polymerase chain | 11 |
rna structure | 11 |
cell immunity | 11 |
natural killer | 11 |
may lead | 11 |
deletion mutants | 11 |
neuronal infection | 11 |
viral families | 11 |
infected patients | 11 |
absolutely required | 11 |
bk virus | 11 |
rubella virus | 11 |
one mouse | 11 |
nucleotide exchange | 11 |
evidence suggests | 11 |
elongation factor | 11 |
new hosts | 11 |
high degree | 11 |
rna duplex | 11 |
escape variant | 11 |
solvent exposed | 11 |
red fluorescent | 11 |
effector function | 11 |
increased polysome | 11 |
protein interacts | 11 |
strand dna | 11 |
sequence motifs | 11 |
done using | 11 |
specific activity | 11 |
kinase inhibitor | 11 |
distress syndrome | 11 |
tetraspanin cd | 11 |
mrna translation | 11 |
also reported | 11 |
small number | 11 |
new species | 11 |
laser scanning | 11 |
jc virus | 11 |
plaque reduction | 11 |
induced genes | 11 |
infected ptx | 11 |
highly attenuated | 11 |
virus core | 11 |
per ml | 11 |
neighboring cells | 11 |
assess whether | 11 |
rtc formation | 11 |
analysis reveals | 11 |
derived ros | 11 |
primary sequence | 11 |
kb activation | 11 |
specific rna | 11 |
biochemical studies | 11 |
highly similar | 11 |
pcr assay | 11 |
highly susceptible | 11 |
emcv infection | 11 |
lytic cycle | 11 |
relationships among | 11 |
sg rna | 11 |
mhv entry | 11 |
young children | 11 |
hcv particle | 11 |
novel picornaviruses | 11 |
model building | 11 |
sirna screen | 11 |
oxygen species | 11 |
tumor suppressor | 11 |
observed expected | 11 |
coronavirus receptor | 11 |
findings provide | 11 |
host genome | 11 |
fetal brain | 11 |
chain reaction | 11 |
rna copies | 11 |
mcherry gfp | 11 |
suckling mice | 11 |
green fluorescence | 11 |
human viral | 11 |
relative abundance | 11 |
high dose | 11 |
rma orf | 11 |
primary screen | 11 |
three experiments | 11 |
independent biological | 11 |
purified virus | 11 |
double stranded | 11 |
virus surface | 11 |
fold decrease | 11 |
cucumber necrosis | 11 |
chloride ion | 11 |
mice displayed | 11 |
qpcr analysis | 11 |
recombinant ceacam | 11 |
dna virus | 11 |
protruded helix | 11 |
software version | 11 |
sorption experiments | 11 |
endou activity | 11 |
results demonstrated | 11 |
protein receptor | 11 |
studies showed | 11 |
high functional | 11 |
one hand | 11 |
plant cells | 11 |
mie transcripts | 11 |
increased numbers | 11 |
serine protease | 11 |
default parameters | 11 |
nw clade | 11 |
becton dickinson | 11 |
ray crystal | 11 |
multiplicative factor | 11 |
plant pathogen | 11 |
units ml | 11 |
silver staining | 11 |
protein sorting | 11 |
egf stimulation | 11 |
different virus | 11 |
denv serotypes | 11 |
transmembrane proteins | 11 |
read length | 11 |
functional mapping | 11 |
profiling reveals | 11 |
programmed cell | 11 |
avian viruses | 11 |
expression patterns | 11 |
orf protein | 11 |
also assessed | 11 |
thermolysin treatment | 11 |
main chain | 11 |
protein transport | 11 |
nucleotide sequences | 11 |
representative experiment | 11 |
take place | 11 |
affinity purification | 11 |
transferred onto | 11 |
gxxxg motif | 11 |